Adverse effects · adult, ethnic minority groups: Latino immigrants, elderly Chinese immigrants, self‐described Americans of African heritage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any outcome considered an adverse effect · adult, ethnic minority groups: Latino immigrants, elderly Chinese immigrants, self‐described Americans of African heritage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of treatment per person at 1 year · adult, ethnic minority groups: Latino immigrants, elderly Chinese immigrants, self‐described Americans of African heritage
1 finding from 1 review
BMI (kg/m2), 12 months from baseline · adult, ethnic minority group: self‐described Americans of African heritage
1 finding from 1 review
Changes in dietary composition, 12 months from baseline · adult, ethnic minority group: self‐described Americans of African heritage
1 finding from 1 review
Physical activity · adult, ethnic minority group: self‐described Americans of African heritage
1 finding from 1 review
6‐Month abstinence ‐ homozygous major · people who smoke
Active NRT leads to higher abstinence at 6 months ‐ homozygous major compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (high certainty).
1 finding from 1 review
6‐Month abstinence ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in abstinence at 6 months ‐ heterozygous or homozygous minor compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (low certainty).
1 finding from 1 review
Abstinence · people who smoke
Active NRT showed no clear difference in abstinence at end of treatment compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (moderate certainty).
2 findings from 1 review
Abstinence at end of treatment ‐ homozygous major · people who smoke
Active NRT leads to higher abstinence at end of treatment ‐ homozygous major compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (high certainty).
1 finding from 1 review
Abstinence at end of treatment ‐ heterozygous or homozygous minor · people who smoke
Active NRT probably leads to lower abstinence at end of treatment ‐ heterozygous or homozygous minor compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
Abstinence · people who smoke
Active NRT showed no clear difference in 6‐Month abstinence compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (low certainty).
1 finding from 1 review
6‐Month abstinence ‐ homozygous major · people who smoke
It is very uncertain whether active NRT changes 6‐Month abstinence ‐ homozygous major compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (very low certainty).
1 finding from 1 review
6‐Month abstinence ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in 6‐Month abstinence ‐ heterozygous or homozygous minor compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
End of treatment · people who smoke
Active NRT showed no clear difference in end of treatment compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (low certainty).
1 finding from 1 review
End of treatment ‐ homozygous major · people who smoke
Active NRT showed no clear difference in end of treatment ‐ homozygous major compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (low certainty).
1 finding from 1 review
End of treatment ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in end of treatment ‐ heterozygous or homozygous minor compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
Intervention not reported
PIPP score intra procedure Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) · neonates with pain associated with orogastric tube insertion
1 finding from 1 review
Intervention not reported
PIPP score 30 seconds post procedure Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) · neonates with pain associated with orogastric tube insertion
1 finding from 1 review
Intervention not reported
PIPP score 1 min post procedure Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) · neonates with pain associated with orogastric tube insertion
1 finding from 1 review